|
|
washingtonpost.com
>
Business
>
Company Research
>
Post 200
 | Top Biotech Companies
| Rank | Company | Revenue
(in mil.) | Net Income
(in mil.) | Employees | | 1 | MedImmune | $618.7 | $149.0 | 1,435 | | 2 | Celera Genomics | 89.4 | -186.2 | 817 | | 3 | BioReliance | 69.7 | 5.9 | 575 | | 4 | Gene Logic | 43.3 | -33.2 | 272 | | 5 | Digene | 34.2 | -6.5 | 210 | | 6 | Igen International | 31.4 | -43.3 | 360 | | 7 | InforMax | 25.2 | -21.4 | 223 | | 8 | Novavax | 24.1 | -9.7 | 183 | | 9 | Guilford Pharmaceuticals | 20.5 | -11.4 | 289 | | 10 | Martek Biosciences | 18.8 | -13.7 | 166 | | 11 | Human Genome Sciences | 12.8 | -117.2 | 1,010 | | 12 | PharmaKinetics Laboratories | 8.9 | -0.513 | 96 | | 13 | United Therapeutics | 5.7 | -37.3 | 128 | |
© 2002-2005 The Washington Post Company
|
|
|
Post 200